Ftse Mib
33.771,75
0,07%
DAX
17.896,50
-0,14%
S&P 500
5.070,17
1,03%
NASDAQ
15.858,70
1,62%
Bitcoin
59.166,92
1,60%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mustang Bio Inc (MBIO) Mustang Bio Inc (MBIO) Notizie

Mustang Bio Inc

MBIO
0,289
0,0289 (11,11%)
Ultimo aggiornamento: 21:09:29
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202402:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
28/3/202414:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
11/3/202421:30EDGAR2Form 8-K - Current report
11/3/202421:05GLOBEMustang Bio Reports Full-Year 2023 Financial Results and..
11/3/202421:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202413:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
14/2/202422:15EDGAR2Form 8-K - Current report
25/1/202422:07EDGAR2Form 8-K - Current report
11/1/202414:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
04/1/202422:05EDGAR2Form 8-K - Current report
19/12/202322:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/12/202303:52EDGAR2Form S-1 - General form for registration of securities under..
11/12/202314:37EDGAR2Form 8-K - Current report
11/12/202314:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
14/11/202322:44EDGAR2Form 8-K - Current report
14/11/202322:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
03/11/202320:22EDGAR2Form D - Notice of Exempt Offering of Securities
02/11/202321:05EDGAR2Form 8-K - Current report
02/11/202314:28GLOBEMustang Bio Announces MB-106 CD20-Targeted CAR-T Data..
30/10/202319:57EDGAR2Form 8-K - Current report
30/10/202319:15GLOBEMustang Bio Announces Closing of $4.4 Million Registered..
30/10/202315:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/10/202322:05EDGAR2Form 8-K - Current report
26/10/202318:30GLOBEMustang Bio Announces $4.4 Million Registered Direct..
26/10/202315:00GLOBEMustang Bio Announces FDA Acceptance of IND Application for..
04/10/202322:05EDGAR2Form 8-K - Current report
16/8/202314:56EDGAR2Form 8-K - Current report
14/8/202322:10EDGAR2Form 8-K - Current report
14/8/202322:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
14/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202314:40EDGAR2Form 8-K - Current report
20/7/202323:30EDGAR2Form 8-K - Current report
11/7/202314:05EDGAR2Form 8-K - Current report
07/7/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202314:05EDGAR2Form 8-K - Current report
15/5/202322:01GLOBEFortress Biotech Reports First Quarter 2023 Financial..
Apertura: 0,2699 Min: 0,2699 Max: 0,29
Chiusura: 0,2601

La tua Cronologia

NASDAQ
MBIO
Mustang Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network